These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1292771)

  • 1. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
    Vogl TJ; Hammerstingl R; Schnell B; Eibl-Eibesfeldt B; Peqios W; Lissner J
    Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
    Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
    Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
    Rummeny EJ; Peters PE
    Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
    Giovagnoni A; Paci E
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
    Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
    Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.
    Sheppard D; Allan L; Martin P; McLeay T; Milne W; Houston JG
    J Magn Reson Imaging; 2004 Aug; 20(2):256-63. PubMed ID: 15269951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography.
    Fayad LM; Holland GA; Bergin D; Iqbal N; Parker L; Curcillo PG; Kowalski TE; Park P; Intenzo C; Mitchell DG
    J Magn Reson Imaging; 2003 Oct; 18(4):449-60. PubMed ID: 14508782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
    Burke C; Alexander Grant L; Goh V; Griffin N
    Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
    Vogl TJ; Hamm B; Schnell B; Eibl-Eibesfeldt B; Steiner S; Lissner J
    Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble-type hepatobiliary contrast agents for MR imaging.
    de Haën C; Gozzini L
    J Magn Reson Imaging; 1993; 3(1):179-86. PubMed ID: 8428085
    [No Abstract]   [Full Text] [Related]  

  • 11. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography.
    Ayuso JR; Ayuso C; Bombuy E; De Juan C; Llovet JM; De Caralt TM; Sánchez M; Pagés M; Bruix J; García-Valdecasas JC
    Liver Transpl; 2004 Nov; 10(11):1391-7. PubMed ID: 15497156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent].
    Steudel A; Layer G; Kraheck H; Hartlapp J; Reiser M
    Rofo; 1992 May; 156(5):460-4. PubMed ID: 1596550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New contrast agents for imaging the liver.
    Helmberger T; Semelka RC
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):745-66, vi. PubMed ID: 11694436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM; Earls JP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings.
    Ergen FB; Akata D; Sarikaya B; Kerimoglu U; Hayran M; Akhan O; Hussain HK
    J Comput Assist Tomogr; 2008; 32(1):54-60. PubMed ID: 18303288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
    De Gaspari A; De Cobelli F; Del Maschio A
    Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced MR imaging of the pancreas.
    Kettritz U; Semelka RC
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.